China Sustained Release Injectables Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Sustained Release Injectables industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Taiwan Liposome Company

    • Ascendis Pharma

    • Sanofi

    • AstraZeneca

    • Aurobindo

    • Alkermes

    • Critical Pharmaceuticals

    • Camurus

    • Avadel

    • Roche

    • Amylin

    • Eli Lilly

    By Type:

    • Naltrexone

    • Other

    • Exenatide

    • Estradiol

    By Application:

    • Diabetes

    • Acromegaly

    • Leukemia

    • Other

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Sustained Release Injectables Market Overview 2018-2029

    • 1.1 China Sustained Release Injectables Industry Development Overview

    • 1.2 China Sustained Release Injectables Industry Development History

    • 1.3 China Sustained Release Injectables Industry Market Size (2018-2029)

    • 1.4 China Sustained Release Injectables Market Analysis by Type from Production Side

      • 1.4.1 China Sustained Release Injectables Production Volume, Production Value and Growth Rate of Naltrexone (2018-2029)

      • 1.4.2 China Sustained Release Injectables Production Volume, Production Value and Growth Rate of Other (2018-2029)

      • 1.4.3 China Sustained Release Injectables Production Volume, Production Value and Growth Rate of Exenatide (2018-2029)

      • 1.4.4 China Sustained Release Injectables Production Volume, Production Value and Growth Rate of Estradiol (2018-2029)

    • 1.5 China Sustained Release Injectables Market Analysis by Application from Consumption End

      • 1.5.1 China Sustained Release Injectables Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)

      • 1.5.2 China Sustained Release Injectables Sales Volume, Sales Value and Growth Rate of Acromegaly (2018-2029)

      • 1.5.3 China Sustained Release Injectables Sales Volume, Sales Value and Growth Rate of Leukemia (2018-2029)

      • 1.5.4 China Sustained Release Injectables Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • 1.6 China Sustained Release Injectables Market Analysis by Region

      • 1.6.1 North China Sustained Release Injectables Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Sustained Release Injectables Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Sustained Release Injectables Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Sustained Release Injectables Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Sustained Release Injectables Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Sustained Release Injectables Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Sustained Release Injectables Market Size and Growth Rate from 2018-2029

    Chapter 2 China Sustained Release Injectables Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Sustained Release Injectables Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Sustained Release Injectables Market Status and Competition Analysis in 2023

      • 2.2.3 China Sustained Release Injectables Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Sustained Release Injectables Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Sustained Release Injectables Industry Development

    Chapter 3 Sustained Release InjectablesIndustry Chain Analysis

    • 3.1 Sustained Release Injectables Industry Chain

    • 3.2 Sustained Release Injectables Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Sustained Release Injectables Market

    • 3.3 Sustained Release Injectables Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Sustained Release Injectables Market

    Chapter 4 China Sustained Release Injectables Market, by Type

    • 4.1 China Sustained Release Injectables Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Sustained Release Injectables Total Production Volume and Growth Rate from Production Side

    • 4.5 China Sustained Release Injectables Production Volume and Growth Rate, by Type

      • 4.5.1 China Sustained Release Injectables Production Volume and Growth Rate of Naltrexone

      • 4.5.2 China Sustained Release Injectables Production Volume and Growth Rate of Other

      • 4.5.3 China Sustained Release Injectables Production Volume and Growth Rate of Exenatide

      • 4.5.4 China Sustained Release Injectables Production Volume and Growth Rate of Estradiol

    Chapter 5 China Sustained Release Injectables Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Sustained Release Injectables Total Market Size and Growth Rate from Consumption End

    • 5.5 China Sustained Release Injectables Market Size and Growth Rate, by Application

      • 5.5.1 China Sustained Release Injectables Market Size and Growth Rate of Diabetes

      • 5.5.2 China Sustained Release Injectables Market Size and Growth Rate of Acromegaly

      • 5.5.3 China Sustained Release Injectables Market Size and Growth Rate of Leukemia

      • 5.5.4 China Sustained Release Injectables Market Size and Growth Rate of Other

    Chapter 6 China Sustained Release Injectables Market, by Region

    • 6.1 China Sustained Release Injectables Production Volume and Production Value, by Region

    • 6.2 China Sustained Release Injectables Sales Volume and Sales Value, by Region

    Chapter 7 North China Sustained Release Injectables Market Analysis

    • 7.1 North China Sustained Release Injectables Market, by Type

    • 7.2 North China Sustained Release Injectables Market, by Application

    Chapter 8 Central China Sustained Release Injectables Market Analysis

    • 8.1 Central China Sustained Release Injectables Market, by Type

    • 8.2 Central China Sustained Release Injectables Market, by Application

    Chapter 9 South China Sustained Release Injectables Market Analysis

    • 9.1 South China Sustained Release Injectables Market, by Type

    • 9.2 South China Sustained Release Injectables Market, by Application

    Chapter 10 East China Sustained Release Injectables Market Analysis

    • 10.1 East China Sustained Release Injectables Market, by Type

    • 10.2 East China Sustained Release Injectables Market, by Application

    Chapter 11 Northeast China Sustained Release Injectables Market Analysis

    • 11.1 Northeast China Sustained Release Injectables Market, by Type

    • 11.2 Northeast China Sustained Release Injectables Market, by Application

    Chapter 12 Southwest China Sustained Release Injectables Market Analysis

    • 12.1 Southwest China Sustained Release Injectables Market, by Type

    • 12.2 Southwest China Sustained Release Injectables Market, by Application

    Chapter 13 Northwest China Sustained Release Injectables Market Analysis

    • 13.1 Northwest China Sustained Release Injectables Market, by Type

    • 13.2 Northwest China Sustained Release Injectables Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Taiwan Liposome Company

        • 14.1.1 Taiwan Liposome Company Company Profile

        • 14.1.2 Taiwan Liposome Company Sustained Release Injectables Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Ascendis Pharma

        • 14.2.1 Ascendis Pharma Company Profile

        • 14.2.2 Ascendis Pharma Sustained Release Injectables Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Sanofi

        • 14.3.1 Sanofi Company Profile

        • 14.3.2 Sanofi Sustained Release Injectables Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 AstraZeneca

        • 14.4.1 AstraZeneca Company Profile

        • 14.4.2 AstraZeneca Sustained Release Injectables Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Aurobindo

        • 14.5.1 Aurobindo Company Profile

        • 14.5.2 Aurobindo Sustained Release Injectables Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Alkermes

        • 14.6.1 Alkermes Company Profile

        • 14.6.2 Alkermes Sustained Release Injectables Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Critical Pharmaceuticals

        • 14.7.1 Critical Pharmaceuticals Company Profile

        • 14.7.2 Critical Pharmaceuticals Sustained Release Injectables Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Camurus

        • 14.8.1 Camurus Company Profile

        • 14.8.2 Camurus Sustained Release Injectables Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Avadel

        • 14.9.1 Avadel Company Profile

        • 14.9.2 Avadel Sustained Release Injectables Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Roche

        • 14.10.1 Roche Company Profile

        • 14.10.2 Roche Sustained Release Injectables Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Amylin

        • 14.11.1 Amylin Company Profile

        • 14.11.2 Amylin Sustained Release Injectables Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Eli Lilly

        • 14.12.1 Eli Lilly Company Profile

        • 14.12.2 Eli Lilly Sustained Release Injectables Market Performance

        • 14.12.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Sustained Release Injectables Industry Research Conclusions

    • 15.2 Sustained Release Injectables Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Sustained Release Injectables Industry Market Size (2018-2029)

    • Figure China Sustained Release Injectables Production Volume, Production Value and Growth Rate of Naltrexone (2018-2029)

    • Figure China Sustained Release Injectables Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Sustained Release Injectables Production Volume, Production Value and Growth Rate of Exenatide (2018-2029)

    • Figure China Sustained Release Injectables Production Volume, Production Value and Growth Rate of Estradiol (2018-2029)

    • Figure China Sustained Release Injectables Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)

    • Figure China Sustained Release Injectables Sales Volume, Sales Value and Growth Rate of Acromegaly (2018-2029)

    • Figure China Sustained Release Injectables Sales Volume, Sales Value and Growth Rate of Leukemia (2018-2029)

    • Figure China Sustained Release Injectables Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure North China Sustained Release Injectables Market Size and Growth Rate from 2018-2029

    • Figure Central China Sustained Release Injectables Market Size and Growth Rate from 2018-2029

    • Figure South China Sustained Release Injectables Market Size and Growth Rate from 2018-2029

    • Figure East China Sustained Release Injectables Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Sustained Release Injectables Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Sustained Release Injectables Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Sustained Release Injectables Market Size and Growth Rate from 2018-2029

    • Figure Sustained Release Injectables Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Sustained Release Injectables Market Share by Type in 2018

    • Figure China Sustained Release Injectables Market Share by Type in 2023

    • Figure China Sustained Release Injectables Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Sustained Release Injectables Production Volume and Growth Rate of Naltrexone (2018-2023)

    • Figure China Sustained Release Injectables Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Sustained Release Injectables Production Volume and Growth Rate of Exenatide (2018-2023)

    • Figure China Sustained Release Injectables Production Volume and Growth Rate of Estradiol (2018-2023)

    • Figure China Sustained Release Injectables Market Share by Application in 2018

    • Figure China Sustained Release Injectables Market Share by Application in 2023

    • Figure China Sustained Release Injectables Total Market Size and Growth Rate from Consumption End

    • Figure China Sustained Release Injectables Market Size and Growth Rate of Diabetes (2018-2023)

    • Figure China Sustained Release Injectables Market Size and Growth Rate of Acromegaly (2018-2023)

    • Figure China Sustained Release Injectables Market Size and Growth Rate of Leukemia (2018-2023)

    • Figure China Sustained Release Injectables Market Size and Growth Rate of Other (2018-2023)

    • Table China Sustained Release Injectables Production Volume by Region (2018-2023)

    • Table China Sustained Release Injectables Production Volume Share by Region (2018-2023)

    • Figure China Sustained Release Injectables Production Volume Share by Region (2018-2023)

    • Table China Sustained Release Injectables Production Value by Region (2018-2023)

    • Table China Sustained Release Injectables Production Value Share by Region (2018-2023)

    • Figure China Sustained Release Injectables Production Value Share by Region (2018-2023)

    • Table China Sustained Release Injectables Sales Volume by Region (2018-2023)

    • Table China Sustained Release Injectables Sales Volume Share by Region (2018-2023)

    • Figure China Sustained Release Injectables Sales Volume Share by Region (2018-2023)

    • Table China Sustained Release Injectables Sales Value by Region (2018-2023)

    • Table China Sustained Release Injectables Sales Value Share by Region (2018-2023)

    • Figure China Sustained Release Injectables Sales Value Share by Region (2018-2023)

    • Table North China Sustained Release Injectables Production Volume by Type (2018-2023)

    • Table North China Sustained Release Injectables Production Volume Share by Type (2018-2023)

    • Figure North China Sustained Release Injectables Production Volume Share by Type (2018-2023)

    • Table North China Sustained Release Injectables Sales Volume by Application (2018-2023)

    • Table North China Sustained Release Injectables Sales Volume Share by Application (2018-2023)

    • Figure North China Sustained Release Injectables Sales Volume Share by Application (2018-2023)

    • Table Central China Sustained Release Injectables Production Volume by Type (2018-2023)

    • Table Central China Sustained Release Injectables Production Volume Share by Type (2018-2023)

    • Figure Central China Sustained Release Injectables Production Volume Share by Type (2018-2023)

    • Table Central China Sustained Release Injectables Sales Volume by Application (2018-2023)

    • Table Central China Sustained Release Injectables Sales Volume Share by Application (2018-2023)

    • Figure Central China Sustained Release Injectables Sales Volume Share by Application (2018-2023)

    • Table South China Sustained Release Injectables Production Volume by Type (2018-2023)

    • Table South China Sustained Release Injectables Production Volume Share by Type (2018-2023)

    • Figure South China Sustained Release Injectables Production Volume Share by Type (2018-2023)

    • Table South China Sustained Release Injectables Sales Volume by Application (2018-2023)

    • Table South China Sustained Release Injectables Sales Volume Share by Application (2018-2023)

    • Figure South China Sustained Release Injectables Sales Volume Share by Application (2018-2023)

    • Table East China Sustained Release Injectables Production Volume by Type (2018-2023)

    • Table East China Sustained Release Injectables Production Volume Share by Type (2018-2023)

    • Figure East China Sustained Release Injectables Production Volume Share by Type (2018-2023)

    • Table East China Sustained Release Injectables Sales Volume by Application (2018-2023)

    • Table East China Sustained Release Injectables Sales Volume Share by Application (2018-2023)

    • Figure East China Sustained Release Injectables Sales Volume Share by Application (2018-2023)

    • Table Northeast China Sustained Release Injectables Production Volume by Type (2018-2023)

    • Table Northeast China Sustained Release Injectables Production Volume Share by Type (2018-2023)

    • Figure Northeast China Sustained Release Injectables Production Volume Share by Type (2018-2023)

    • Table Northeast China Sustained Release Injectables Sales Volume by Application (2018-2023)

    • Table Northeast China Sustained Release Injectables Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Sustained Release Injectables Sales Volume Share by Application (2018-2023)

    • Table Southwest China Sustained Release Injectables Production Volume by Type (2018-2023)

    • Table Southwest China Sustained Release Injectables Production Volume Share by Type (2018-2023)

    • Figure Southwest China Sustained Release Injectables Production Volume Share by Type (2018-2023)

    • Table Southwest China Sustained Release Injectables Sales Volume by Application (2018-2023)

    • Table Southwest China Sustained Release Injectables Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Sustained Release Injectables Sales Volume Share by Application (2018-2023)

    • Table Northwest China Sustained Release Injectables Production Volume by Type (2018-2023)

    • Table Northwest China Sustained Release Injectables Production Volume Share by Type (2018-2023)

    • Figure Northwest China Sustained Release Injectables Production Volume Share by Type (2018-2023)

    • Table Northwest China Sustained Release Injectables Sales Volume by Application (2018-2023)

    • Table Northwest China Sustained Release Injectables Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Sustained Release Injectables Sales Volume Share by Application (2018-2023)

    • Table Taiwan Liposome Company Company Profile

    • Table Taiwan Liposome Company Sustained Release Injectables Revenue, Price and Gross (2018-2023)

    • Table Ascendis Pharma Company Profile

    • Table Ascendis Pharma Sustained Release Injectables Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Sustained Release Injectables Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Sustained Release Injectables Revenue, Price and Gross (2018-2023)

    • Table Aurobindo Company Profile

    • Table Aurobindo Sustained Release Injectables Revenue, Price and Gross (2018-2023)

    • Table Alkermes Company Profile

    • Table Alkermes Sustained Release Injectables Revenue, Price and Gross (2018-2023)

    • Table Critical Pharmaceuticals Company Profile

    • Table Critical Pharmaceuticals Sustained Release Injectables Revenue, Price and Gross (2018-2023)

    • Table Camurus Company Profile

    • Table Camurus Sustained Release Injectables Revenue, Price and Gross (2018-2023)

    • Table Avadel Company Profile

    • Table Avadel Sustained Release Injectables Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Sustained Release Injectables Revenue, Price and Gross (2018-2023)

    • Table Amylin Company Profile

    • Table Amylin Sustained Release Injectables Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Sustained Release Injectables Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.